The company
Werewolf Therapeutics, Inc.
HOWL · Nasdaq
HOWL stood above a rising 150-day average in 9 of the last 52 weekly readings, including each of the last 7 weeks. It is 56.3% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 7 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $11.0M
- Officials’ trades on record
- 0
- Institutions holding
- 43 (-3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 9 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Luke EvninDirector | sold | 107,429at $0.31 | 7 Jul 2026filed 8 Jul 2026 |
| Luke EvninDirector | sold | 35,770at $0.32 | 6 Jul 2026filed 8 Jul 2026 |
| Luke EvninDirector | sold | 157,084at $0.30 | 29 Jun 2026filed 29 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 389,216at $0.35 | 17 Jun 2026filed 22 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 27,695at $0.35 | 17 Jun 2026filed 22 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 139,686at $0.37 | 16 Jun 2026filed 16 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 9,939at $0.37 | 16 Jun 2026filed 16 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 120,216at $0.39 | 15 Jun 2026filed 16 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 8,554at $0.39 | 15 Jun 2026filed 16 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 159,119at $0.40 | 12 Jun 2026filed 16 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 11,322at $0.40 | 12 Jun 2026filed 16 Jun 2026 |
| Ra Capital Management, L.p.10% owner | sold | 245,066at $0.38 | 11 Jun 2026filed 11 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P.reduced · filed 14 Aug 2026 | 2,387,744$859K | -4,293,563−64.3% |
| Balyasny Asset Management L.P.new · filed 14 Aug 2026 | 1,790,089$644K | +1,790,089 |
| VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 2026 | 1,217,976$438K | 00.0% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 674,632$243K | +158,414+30.7% |
| Lynx1 Capital Management LPunchanged · filed 12 Aug 2026 | 657,786$237K | 00.0% |
| SPHERA FUNDS MANAGEMENT LTD.unchanged · filed 14 Aug 2026 | 626,810$226K | 00.0% |
| DC Funds, LPunchanged · filed 14 Aug 2026 | 589,102$212K | 00.0% |
| Verdad Advisers, LPadded · filed 14 Aug 2026 | 348,709$126K | +318,949+1071.7% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 335,815$121K | -53,672−13.8% |
| BANK OF AMERICA CORPadded · filed 14 Aug 2026 | 311,502$112K | +46,919+17.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.